Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale EVP, Research & CSO sold 4,125 shares at an average $48.63 ($200,585)
  2. 4 Open-market sale Chief Medical Officer sold 7,500 shares at an average $43.45 ($325,841)
  3. 4 Open-market sale EVP, Research & CSO sold 15,125 shares at an average $49.60 ($750,200)
  4. 4 Open-market sale Chief Administrative Officer sold 10,000 shares at $50.00 ($500,000)
  5. 4 Open-market sale Director sold 1,435 shares at $46.25 ($66,369)
  6. 4 Open-market buy Chief Technology Officer bought 11.52 shares at $43.39 ($500)
  7. 4 Other disposition Director disposed of 500,000 shares (other)
  8. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  9. 4 Open-market sale Director sold 15,174 shares at $36.80 ($558,403)
  10. 4 Other disposition Director disposed of 500,000 shares (other)
  11. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  12. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $35.85 ($179,255)
  13. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $32.67 ($44,921)
  14. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $36.47 ($182,331)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $36.94 ($50,793)
  18. 4 Open-market sale Chief Medical Officer sold 4,000 shares at $39.65 ($158,596)
  19. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $38.87 ($53,446)
  20. 4 Open-market sale Director sold 15,174 shares at an average $39.56 ($600,314)

Page 25 of 41 · 806 filings